SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    William C. Howland, Niran J. Amar, William Wheeler, Harry Sacks, Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen, International Forum of Allergy & Rhinology, 2011, 1, 4
  2. 2
    William E Berger, Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis, Expert Opinion on Drug Metabolism & Toxicology, 2009, 5, 1, 91

    CrossRef

  3. 3
    Alkis Togias, Jonathan Correnand, Martin Wagenmann, Middleton's Allergy: Principles and Practice, 2009,

    CrossRef

  4. 4
    Leonard Bielory, Ocular Allergy Treatment, Immunology and Allergy Clinics of North America, 2008, 28, 1, 189

    CrossRef

  5. 5
    Patrik Pipkorn, Candy Costantini, Curt Reynolds, Michael Wall, Margaret Drake, Alvin Sanico, David Proud, Alkis Togias, The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation, Annals of Allergy, Asthma & Immunology, 2008, 101, 1, 82

    CrossRef

  6. 6
    Jonathan A. Bernstein, Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability, Current Medical Research and Opinion, 2007, 23, 10, 2441

    CrossRef

  7. 7
    Christina Lee, Jonathan Corren, Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis, Expert Opinion on Pharmacotherapy, 2007, 8, 5, 701

    CrossRef

  8. 8
    William Berger, Frank Hampel, Jonathan Bernstein, Shailen Shah, Harry Sacks, Eli O. Meltzer, Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2006, 97, 3, 375

    CrossRef

  9. 9
    Craig La Force, Review of the pharmacology, clinical efficacy, and safety of azelastine hydrochloride, Expert Review of Clinical Immunology, 2005, 1, 2, 191

    CrossRef

  10. 10
    William E Berger, Allergic Rhinitis in Children, Pediatric Drugs, 2004, 6, 4, 233

    CrossRef

  11. 11
    Craig F. LaForce, Jonathan Corren, William J. Wheeler, William E. Berger, Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine, Annals of Allergy, Asthma & Immunology, 2004, 93, 2, 154

    CrossRef

  12. 12
    William E. Berger, Martha V. White, Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine, Annals of Allergy, Asthma & Immunology, 2003, 91, 2, 205

    CrossRef

  13. 13
    Alkis Togias, H1-receptors, Journal of Allergy and Clinical Immunology, 2003, 112, 4, S60

    CrossRef

  14. 14
    David S. Pearlman, Jay Grossman, Eli O. Meltzer, Histamine skin test reactivity following single and multiple doses of azelastine nasal sprayin patients with seasonal allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2003, 91, 3, 258

    CrossRef

  15. 15
    William E. Berger, Overview of allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2003, 90, 6, 7

    CrossRef

  16. 16
    Giorgio Ciprandi, Cristina Cosentino, Manlio Milanese, Maria Angela Tosca, Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions, Annals of Allergy, Asthma & Immunology, 2003, 90, 4, 434

    CrossRef

  17. 17
    Duraisamy Kempuraj, Man Huang, Kristiana Kandere, William Boucher, Richard Letourneau, Sheila Jeudy, Kim Fitzgerald, Kathleen Spear, Achilles Athanasiou, Theoharis C. Theoharides, Azelastine is more potent than olopatadine in inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells, Annals of Allergy, Asthma & Immunology, 2002, 88, 5, 501

    CrossRef

  18. 18
    Frances T. Allocco, Virginia Votypka, Marcy deTineo, Robert M. Naclerio, Fuad M. Baroody, Effects of fexofenadine on the early response to nasal allergen challenge, Annals of Allergy, Asthma & Immunology, 2002, 89, 6, 578

    CrossRef

  19. 19
    Supinda Saengpanich, Paraya Assanasen, Marcy deTineo, Lauran Haney, Robert M. Naclerio, Fuad M. Baroody, Effects of Intranasal Azelastine on the Response to Nasal Allergen Challenge, The Laryngoscope, 2002, 112, 1
  20. 20
    Phillip Lieberman, Preclinical evidence of azelastine hydrochloride activity, Current Therapeutic Research, 2002, 63, 9, 556

    CrossRef

  21. 21
    Leonard Bielory, Duraisamy Kempuraj, Theoharis Theoharides, Topical immunopharmacology of ocular allergies, Current Opinion in Allergy and Clinical Immunology, 2002, 2, 5, 435

    CrossRef

  22. 22
    Jean Bousquet, Paul van Cauwenberge, Nikolai Khaltaev, Allergic Rhinitis and Its Impact on Asthma, Journal of Allergy and Clinical Immunology, 2001, 108, 5, S147

    CrossRef

  23. 23
    William E. Berger, Allergic rhinitis in children, Current Allergy and Asthma Reports, 2001, 1, 6, 498

    CrossRef

  24. 24
    Charles H. Banov, Phil Lieberman, Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis, Annals of Allergy, Asthma & Immunology, 2001, 86, 1, 28

    CrossRef

  25. 25
    P. H. Howarth., A comparison of the anti-inflammatory properties of intranasal corticosteroids and antihistamines in allergic rhinitis, Allergy, 2000, 55,
  26. 26
    P. Van Cauwenberge, C. Bachert , G. Passalacqua , J. Bousquet , G. W. Canonica , S. R. Durham , W. J. Fokkens , P. H. Howarth , V. Lund , H.-J. Malling , N. Mygind , D. Passali , G. K. Scadding , D.-Y. Wang , Consensus statement on the treatment of allergic rhinitis, Allergy, 2000, 55, 2
  27. 27
    J. Bousquet, What are the perspectives in the future for H1-antihistamines ?, Revue Française d'Allergologie et d'Immunologie Clinique, 2000, 40, 1, 82

    CrossRef

  28. 28
    Cuss, Beyond the histamine receptor: effect of antihistamines on mast cells, Clinical & Experimental Allergy, 1999, 29, S3
  29. 29
    William E. Berger, Stanley M. Fineman, Phillip Lieberman, Robert M. Miles, Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis, Annals of Allergy, Asthma & Immunology, 1999, 82, 6, 535

    CrossRef

  30. 30
    Henrik H. Jacobi, Per S. Skov, Lars K. Poulsen, Hans-Jørgen Malling, Niels Mygind, Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine, Journal of Allergy and Clinical Immunology, 1999, 103, 5, 768

    CrossRef

  31. 31
    Phil Lieberman, Management of allergic rhinitis with a combination antihistamine/anti-inflammatory agent, Journal of Allergy and Clinical Immunology, 1999, 103, 3, S400

    CrossRef

  32. 32
    Martha White, Mediators of inflammation and the inflammatory process, Journal of Allergy and Clinical Immunology, 1999, 103, 3, S378

    CrossRef

  33. 33
    James Day, Pros and cons of the use of antihistamines in managing allergic rhinitis, Journal of Allergy and Clinical Immunology, 1999, 103, 3, S395

    CrossRef

  34. 34
    David Weldon, DIAGNOSIS AND MANAGEMENT OF RHINITIS, Primary Care: Clinics in Office Practice, 1998, 25, 4, 831

    CrossRef

  35. 35
    MICHAEL W. SIMON, Efficacy of Azelastine in the Treatment of Allergic and Infectious Inflammatory Rhinitis in Childhood, Pediatric Asthma, Allergy & Immunology, 1998, 12, 3, 199

    CrossRef

  36. 36
    G. CIPRANDI, S. BUSCAGLIA, A. CATRULLO, G. PESCE, N. FIORINO, P. MONTAGNA, M. BAGNASCO, G. W. CANONICA, Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity, Clinical & Experimental Allergy, 1997, 27, 2
  37. 37
    Yuhei Hamasaki, Miyanji Shafigeh, Shuichi Yamamoto, Rika Sato, Masafumi Zaitu, Eriko Muro, Ikuko Kobayashi, Tomohiro Ichimaru, Hakaru Tasaki, Sumio Miyazaki, Inhibition of Leukotriene Synthesis by Azelastine, Annals of Allergy, Asthma & Immunology, 1996, 76, 5, 469

    CrossRef

  38. 38
    Craig LaForce, Robert J. Dockhorn, Bruce M. Prenner, Theodore J. Chu, Michael J. Kraemer, Michael D. Widlitz, Thomas A. D'Eletto, Jeffrey J. Freitag, Safety and Efficacy of Azelastine Nasal Spray (Astelin NS) for Seasonal Allergic Rhinitis: a 4-Week Comparative Multicenter Trial, Annals of Allergy, Asthma & Immunology, 1996, 76, 2, 181

    CrossRef

  39. 39
    N. Chand, R. D. Sofia, Azelastine—A Novel In Vivo Inhibitor of Leukotriene Biosynthesis: A Possible Mechanism of Action: A Mini Review, Journal of Asthma, 1995, 32, 3, 227

    CrossRef

  40. 40
    Andrea Pelucchi, Anita Chiapparino, Berardino Mastropasqua, Luigi Marazzini, Alicia Hernandez, Antonio Foresi, Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens, Journal of Allergy and Clinical Immunology, 1995, 95, 2, 515

    CrossRef

  41. 41
    Martin Wagenmann, Fuad M. Baroody, Anne Kagey-Sobotka, Lawrence M. Lichtenstein, Robert M. Naclerio, The effect of terfenadine on unilateral nasal challenge with allergen, Journal of Allergy and Clinical Immunology, 1994, 93, 3, 594

    CrossRef